0001127602-20-008440.txt : 20200228
0001127602-20-008440.hdr.sgml : 20200228
20200228192648
ACCESSION NUMBER: 0001127602-20-008440
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200226
FILED AS OF DATE: 20200228
DATE AS OF CHANGE: 20200228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Herendeen Paul
CENTRAL INDEX KEY: 0001374175
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 20673613
MAIL ADDRESS:
STREET 1: C/O ZOETIS INC.
STREET 2: 100 CAMPUS DRIVE
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bausch Health Companies Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
DATE OF NAME CHANGE: 20100928
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-02-26
0000885590
Bausch Health Companies Inc.
BHC
0001374175
Herendeen Paul
400 SOMERSET CORPORATE BOULEVARD
BRIDGEWATER
NJ
08807
1
EVP and CFO
Common Shares, No Par Value
2020-02-26
4
A
0
63030
0
A
316748
D
Non-qualified Stock Options (right To Purchase)
24.77
2020-02-26
4
A
0
159192
0
A
2030-02-26
Common Shares, No Par Value
159192
159192
D
Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch Health Companies Inc. ("Bausch Health").
The options vest in equal installments on each of the first three anniversaries of the date of grant.
/s/ Kirsten O'Donnell, attorney-in-fact for Paul Herendeen
2020-02-28